Benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate Pregnancy and Breastfeeding Warnings
Brand names: Hyophen, Methylphen, Prosed DS, Uribel Tabs, Urised, Urophen MB
Benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate Pregnancy Warnings
This drug should be used during pregnancy only if the benefit outweighs the risk.
US FDA pregnancy category: C
Comments:
-Hyoscyamine and methenamine cross the placenta.
This drug combination has not been studied in animals or humans. It is unknown if it could cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Yes (hyoscyamine, methenamine); Data not available (benzoic acid, methylene blue, phenyl salicylate)
Comments:
-The effects on the nursing infant are unknown.
See also
References for pregnancy information
- (2016) "Product Information. Hyophen (benzoic acid/hyoscy/methen/mblue/phenylsal)." BioComp Pharma
References for breastfeeding information
- (2016) "Product Information. Hyophen (benzoic acid/hyoscy/methen/mblue/phenylsal)." BioComp Pharma
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.